Next |
home / stock / eftr / eftr message board
Subject | By | Source | When |
---|---|---|---|
Fake wall needs to get obliterated | Ardilla | investorshub | 01/20/2023 8:54:56 PM |
Does this have a collaboration with Pfizer and | Ardilla | investorshub | 01/20/2023 7:03:48 AM |
JMP Securities Sticks to Their Buy Rating for | crudeoil24 | investorshub | 08/11/2022 11:27:16 AM |
THANKS, C-O-24!! (Always appreciated!!) | Invest-in-America | investorshub | 08/10/2022 4:59:23 PM |
Ratcheting up along with R*$SLS. | crudeoil24 | investorshub | 08/10/2022 4:53:00 PM |
$EFTR: I copy that, CPT.!! Thanks!! (& they | Invest-in-America | investorshub | 08/10/2022 2:14:17 AM |
Therapeutics is a Strong Buy with an average | crudeoil24 | investorshub | 08/10/2022 12:41:53 AM |
.65 in AH > oversold! > Mizuho Securities | crudeoil24 | investorshub | 08/10/2022 12:41:30 AM |
EFTR: What??? Nobody here??? | Invest-in-America | investorshub | 08/09/2022 3:42:08 PM |
So Do u trust this POS | ipo_dude | investorshub | 10/08/2021 5:38:16 AM |
This pos keeps going down, no sign to stabilize?? | Roadtojourney | investorshub | 09/28/2021 3:07:04 PM |
Take a look at Surrozen warrants $SRZNW. | macnai | investorshub | 09/17/2021 1:32:14 PM |
I have sent an email to Investor relations | macnai | investorshub | 09/11/2021 11:10:38 PM |
I think the warrant is exercisable on January | petermic | investorshub | 09/10/2021 7:17:07 PM |
Hi - you sound like you would know. | petermic | investorshub | 09/10/2021 6:39:03 PM |
Profile of DAVIDE RUGGERO, PH.D. Co-Founder of eFFECTOR | macnai | investorshub | 09/09/2021 8:35:35 PM |
If the stock price settles down at $20 | macnai | investorshub | 09/09/2021 3:34:04 PM |
The possibility to treat Cancer and Obesity. | macnai | investorshub | 09/09/2021 3:18:02 PM |
Cancer-focused biotechnology company eFFECTOR went public in late | crudeoil24 | investorshub | 09/08/2021 6:38:13 PM |
$EFTR : I bet Chris Erlich is a | makinezmoney | investorshub | 09/08/2021 6:22:28 PM |
News, Short Squeeze, Breakout and More Instantly...
eFFECTOR Therapeutics Inc. Company Name:
EFTR Stock Symbol:
NASDAQ Market:
SOLANA BEACH, Calif. and REDWOOD CITY, Calif., May 20, 2024 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR), a leader in the development of selective translation regulator inhibitors (STRIs) for the treatment of cancer, today announced a collaboration to conduct an investigator-spo...
Dose escalation of zotatifin in the ZFA triplet ongoing at 0.14 mg/kg, with RP2D expected in H2 2024 Raised $15.0 million in gross proceeds from registered direct financing, extending cash runway into first quarter of 2025 SOLANA BEACH, Calif. and REDWOOD CITY, Calif., May 09, 202...
SOLANA BEACH, Calif. and REDWOOD CITY, Calif., April 09, 2024 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR), a leader in the development of selective translation regulator inhibitors (“STRIs”) for the treatment of cancer, today announced that the Company will presen...